Dexcom (DXCM) Other Non-Current Assets (2010 - 2026)

Dexcom's (DXCM) quarterly Other Non-Current Assets came in at $285.9 million in Q1 2026, up 69.67% year-on-year from $168.5 million in Q1 2025, and up 2.58% on a QoQ basis from $278.7 million in Q4 2025.

Dexcom (DXCM) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Dexcom (DXCM) has 17 years of Other Non-Current Assets data on file, last reported at $285.9 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 69.67% year-over-year to $285.9 million in Q1 2026; TTM through Mar 2026 was $285.9 million, a 69.67% increase from a year earlier, with the FY2025 full-year figure at $278.7 million, up 61.1% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $285.9 million, up from $278.7 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for DXCM reached as high as $285.9 million in Q1 2026 and fell as low as $22.8 million in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $118.1 million across 5 years, with a median of $77.7 million in 2024.
  • On a YoY basis, Other Non-Current Assets climbed as much as 348.57% in 2022 and fell as far as 6.44% in 2022.
  • Year by year, Other Non-Current Assets stood at $47.1 million in 2022, then soared by 59.24% to $75.0 million in 2023, then surged by 130.67% to $173.0 million in 2024, then jumped by 61.1% to $278.7 million in 2025, then gained by 2.58% to $285.9 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $285.9 million in Q1 2026, $278.7 million in Q4 2025, and $276.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 3.17 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 4.15 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 2.05 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 738.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 285.90 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 828.89 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.25 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 164.00 Mn
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 211.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 285.90 Mn
Dec 31, 2025 278.70 Mn
Sep 30, 2025 276.50 Mn
Jun 30, 2025 175.50 Mn
Mar 31, 2025 168.50 Mn
Dec 31, 2024 173.00 Mn
Sep 30, 2024 88.20 Mn
Jun 30, 2024 82.90 Mn
Mar 31, 2024 77.70 Mn
Dec 31, 2023 75.00 Mn
Sep 30, 2023 74.40 Mn
Jun 30, 2023 66.90 Mn
Mar 31, 2023 56.60 Mn
Dec 31, 2022 47.10 Mn
Sep 30, 2022 33.70 Mn
Jun 30, 2022 24.80 Mn
Mar 31, 2022 22.80 Mn
Dec 31, 2021 10.50 Mn
Jun 30, 2021 23.30 Mn
Mar 31, 2021 20.40 Mn